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Abstract
Translating the vast data generated by genomic platforms into reliable predictions of
clinical outcomes remains a critical challenge in realizing the promise of genomic medicine
largely due to small number of independent samples. In this paper, we show that neural
networks can be trained to predict clinical outcomes using heterogeneous genomic data
sources via multi-task learning and adversarial representation learning, allowing one to
combine multiple cohorts and outcomes in training. We compare our proposed method to
two baselines and demonstrate that it can be used to help mitigate the data scarcity and
clinical outcome censorship in cancer genomics learning problems.
1. Introduction
Since the emergence of high throughput experiments such as Next Generation Sequencing,
the volume of genomic data produced has been increasing exponentially (Stephens et al.,
2015). A single biopsy can generate tens of thousands of transcriptomic, proteomic, or
epigenetic features. The ability to generate genomic data has far outpaced the ability to
translate these data into clinically-actionable information, as typically only a handful of
molecular features are used in diagnostics or in determining prognosis (Bailey et al., 2018;
Van De Vijver et al., 2002; Network, 2015).
Machine-learning has emerged as a powerful tool for analyzing high-dimensional data,
with open software tools that enable scalable and distributed data analysis. A sub-field
of machine learning, known as deep learning, has recently achieved remarkable success in
learning from high dimensional images and sequences (LeCun et al., 2015). It involves
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artificial neural networks with several processing layers that learn representations of data
with multiple abstraction levels.
There are several challenges in applying neural networks to genomic data (Min et al.,
2017). The more parameters a machine learning model has, the more independent sam-
ples it requires for training (Abu-Mostafa, 1989), and neural networks often have many
thousands of parameters due to their layered nature. Cancer genomic datasets often have
small sample size (only hundreds of samples), and much larger dimensionality (tens of
thousands of features). Several approaches have been employed to alleviate this data in-
sufficiency including dimensionality reduction, feature selection, data augmentation, and
transfer learning (Ching et al., 2018).
An alternative approach is to integrate genomic data from multiple studies and hospitals
(for example, two independent studies of breast cancer genomics) to increase training set
size. Heterogeneity of available genomic datasets due to technical and sample biases poses
challenges to integrating multiple data sources. Cohorts from multiple sources typically have
difference demographic or disease stage distributions, may be subject to different signal
capture calibration, post-processing artifacts, and naming conventions. This means that
naively combining heterogeneous cohorts is both difficult and may degrade model accuracy
due to batch effects (Tom et al., 2017).
In addition to integrating data from studies involving the same primary cancer site, we
may benefit from pooling cohorts diagnosed with different cancer types together to increase
training size. Cancers that originate from different primary sites are known to have large
differences in genetic markup, although there are some remarkable similarities that seem to
play a fundamental role in carcinogenesis (Hoadley et al., 2018; Bailey et al., 2018; Hanahan
and Weinberg, 2011). The idea of combining multiple cancer types relies on the premise
that models of sufficient complexity and constraints can exploit these similarities to improve
outcome prediction.
In this paper we propose a multi-task learning and adversarial representation learning
approach that allows integration of heterogeneous cohorts. Experiments demonstrate that
our proposed methods can be used to alleviate the data scarcity issue in several cancer
genomics learning problems.
Technical Significance Building upon SurvivalNet (Yousefi et al., 2016, 2017) -a neural
network model for survival prediction- we propose a multi-task learning approach that
enables: a) training SurvivalNet on multiple heterogeneous data sources while avoiding
the issues that arise from naively combining datasets, and b) training on multiple clinical
outcomes from the same cohort, thus helping to address the issue of censorship (loss to
follow-up) often encountered in clinical datasets. We further enhance our proposed method
by introducing an adversarial cohort classification loss that prevents the model from learning
cohort-specific noise, thus enabling task-invariant representation learning.
Clinical Relevance Accurate prognostication is crucial to clinical decision making in
cancer treatment. Although contemporary sequencing platforms can provide tens to hun-
dreds of thousands of features describing the molecular profiles of neoplastic cells, only a
small number of these features have established clinical significance and are used in prog-
nostication. Using machine learning to make reliable and accurate predictions of clinical
outcomes from high-dimensional molecular data is a major step in realizing the promise of
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precision medicine, but has been challenged so far by sample size limitations. This paper
aims to address this data insufficiency challenge using techniques that allow training of
neural networks on multiple heterogeneous cohorts. The prospect of increasing the train-
ing set size by integrating cohorts from different hospitals or studies, and exploiting traits
shared among all human cancer types, to train powerful predictive models motivates the
task-invariant representation learning approach proposed in this paper.
2. Background and Related Work
2.1. Survival analysis with Cox proportional hazards model
Survival analysis refers to any problem where the variable of interest is time to some event,
which in cancer is often death or progression of disease. Time-to-event modelling is different
from ordinary regression due to a specific type of missing data problem known as censoring.
Incomplete or censored observations are important to incorporate into the model since they
could provide critical information about long-term survivors (Harrell Jr, 2015). The most
widely used approach to survival analysis is the semi-parametric Cox proportional hazards
model (Cox, 1972). It models the hazard function at time s given the predictors xi of the
ith sample as:
h(s|xi, β) = h0(s)eβ>xi (1)
The model parameters β are estimated by minimizing Cox’s negative partial log-likelihood:
Lcox(X,Y, β) = −
∑
xi∈U
(
β>xi − log
∑
j∈Ri
eβ
>xj
)
(2)
where X = {x1, ..., xN} are the samples, and Y = {E,S} represents label vectors of event
or last follow-up times S = {s1, ..., sN} and event status E = {e1, ..., eN}. For censored
samples (e = 0), s represents time of last follow-up while for observed samples (e = 1), it
represents event time. The outer sum is over the set of uncensored samples U and Ri is
the set of at-risk samples with sj ≥ si. The baseline hazard h0(t) is cancelled out of the
likelihood and can remain unspecified.
We will look at two variants of Cox’s model that are used in this paper as baselines.
Park and Hastie (2007) proposed Cox-ElasticNet which minimizes Cox’s loss subject to the
elasticnet regularization constraint:
LCEN (X,Y, β) = Lcox(X,Y, β) + γ(α‖β‖1 + (1− α)‖β‖22) (3)
where α ∈ [0, 1] is the mixture coefficient of `1 and `2 regularization terms, and γ ∈
[0,+ inf) is the overall regularization rate.
A non-linear alternative to Cox regression is SurvivalNet (Yousefi et al., 2016, 2017), a
fully connected artificial neural network fW with parameters W that replaces X in Equation
2 with its non-linear transformation fW (X). SurvivalNet has been shown to outperform
other common survival analysis techniques such as random survival forests (Ishwaran et al.,
2008) and Cox-ElasticNet.
This paper proposes two multi-task learning models built upon SurvivalNet to learn task-
invariant representations from heterogeneous data sources. These models will be discussed
in detail in section 4.
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2.2. Multi-task learning for survival analysis
Both theoretical and empirical studies show that learning multiple related tasks simultane-
ously often significantly improves performance relative to learning each task independently
(Baxter, 2000; Ben-David and Schuller, 2003; Caruana, 1997). This is particularly the case
when only a few samples per task are available, since with multi-task learning, each task
has more data to learn from. Multi-task learning has been applied to many areas of ma-
chine learning inlcuding computer vision (Zhang et al., 2014), natural language processing
(Collobert and Weston, 2008), and survival analysis (Wang et al., 2017; Li et al., 2016).
Following Pan and Yang (2010), we provide a classification of multi-task learning prob-
lem settings in cancer survival analysis. Let us first define the terms domain and task.
A domain is a pair {X , P (X)} which includes a feature space and a marginal probability
distribution where X = {x1, ..., xn} ∈ X . A task {Y, P (Y |X)} consists of a label space and
a conditional probability distribution function. P (Y |X) is the ultimate predictive function
that is not observed but can be learned from training data. Multi-task learning, by defini-
tion, involves different tasks, that is different P (Y |X), or even different label spaces. With
that in mind, we classify multi-task survival analysis problems as follows:
1. Different P (X): Data for the tasks come from different distributions. Examples
include:
- Standard gene expression data and progression-free survival labels are available
for all cohorts, but the cohorts are diagnosed with different cancer types.
- Standard gene expression data and progression-free survival labels are available
for all cohorts, and the cohorts are diagnosed with the same cancer types but
belong to different studies/hospitals.
2 Different X : Data for the tasks come from different feature spaces. Note that this
automatically leads to different P (X). Example of different feature spaces are gene
expression data and mutation data.
3. Different P (Y |X): All tasks are the same in nature, but the conditional distribution
of labels are different. For example, learning overall survival and progression-free
survival simultaneously for the same cohort of patients falls under this category.
4 Different Y: This class of multi-task problems involves different prediction tasks (such
as survival analysis and classification).
This paper focuses on scenarios 1 (Sections 5.3 and 5.4) and 3 (5.5). The general form
of the loss function when learning T tasks simultaneously is:
L(Y,X,W ) =
T∑
t=1
Lt(y
t, gt(W t, Xt)) + γλ(Y,X,W ) (4)
lt and W
t, respectively, are the loss function and the parameters of task t. Y = {Y 1, ..., Y T }
and X = {X1, ..., XT } are the combined input data of all t tasks. gt indicates the prediction
function corresponding to task t, and λ is a regularization or auxiliary function that captures
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task relatedness assumptions, examples of which include cluster norm (Jacob et al., 2009),
trace norm (Argyriou et al., 2007), and `1,2 norm (Liu et al., 2009). γ is a weight parameter
controlling the importance of the auxiliary function.
Previous work has applied multi-task learning under different task relatedness assump-
tions to train Cox’s proportional hazards model using multiple genomic data sources (Wang
et al., 2017; Li et al., 2016). In this paper, our main assumption is that gene expression
data lies on a lower dimensional subspace that can be utilized in several prognostic tasks.
We will enforce this assumption via parameter sharing and the bottleneck architecture of
our models as shown in Figure 1. Moreover, In section 4 we describe how an adversar-
ial classification objective can be used as auxiliary function λ to encourage task-invariant
representation learning.
For simplicity, we consider settings with one target task and one auxiliary task (T=2).
Ground truth labels are available for both tasks, and the goal is to make better predictions
on the target task by learning relevant information from the auxiliary task.
2.3. Adversarial representation learning
The idea of using adversarial learning to match two distributions was first proposed by
Goodfellow et al. (2014) for training generative models. In generative adversarial models, a
generator aims to generate realistic data to mislead a discriminator that is simultaneously
trained to distinguish between real and generated data. This competition drives the two
components of the model to improve, until the generated data distribution is indistinguish-
able from the real data distribution.
This idea has been applied to unsupervised domain adaptation for natural language pro-
cessing and computer vision, with varying design choices including parameter sharing, type
of adversarial loss, and discriminative vs. generative base model (Ganin and Lempitsky,
2015; Ganin et al., 2016; Tzeng et al., 2015; Liu and Tuzel, 2016; Tzeng et al., 2017).
We adapt this idea to multi-task learning to encourage our proposed model to learn
task-invariant representations. A cohort discriminator is trained to assign samples to their
cohort. Simultaneously, a SurvivalNet is adversarially trained to confuse the discriminator
by learning a representation of data where samples from different cohorts are indistinguish-
able (in addition to learning to predict survival). This competition will teach SurvivalNet
to avoid learning cohort-specific noise.
3. Cohort
The Cancer Genome Atlas (TCGA) provides publicly available clinical and molecular data
for 33 cancer types. TCGA gene expression features were taken from the Illumina HiSeq
2000 RNA Sequencing V2 platform. TCGA clinical data contains overall survival (OS)
and progression free interval (PFI) labels, with varying degrees of availability for different
primary cancer sites (Liu et al., 2018). This data has been obtained from multiple hospitals
and health-care centers, so a considerable degree of heterogeneity exists within the TCGA.
PFI is defined as the period from the date of diagnosis until the date of the first occur-
rence of a new tumor-related event, which includes progression of the disease, locoregional
recurrence, distant metastasis, new primary tumor, or death with tumor. OS is the period
from the date of diagnosis until the date of death from any cause. Since patients generally
5
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Dataset
Name
Number
of
Samples
Numbr
of
Features
Event
Rate
Event
Type
ACC 79 20531 52% PFI
CESC 304 20531 23% PFI
KIRC 533 20531 30% PFI
KIRP 514 20531 37% PFI
LGG 288 20531 20% PFI
MESO 84 20531 70% PFI
PAAD 178 20531 58% PFI
BRCA 1094 20531 13% OS
METABRIC 1903 24368 33% OS
Table 1: Summary of datasets.
suffer from disease progression or recurrence before dying, PFI requires shorter follow-up
times and has higher event rate. Additionally, OS is a noisy signal due to deaths from
non-cancer causes. Therefore, wherever possible, PFI is used as the outcome variable.
We also used METABRIC (Molecular Taxonomy of Breast Cancer International Con-
sortium) (Curtis et al., 2012) gene expression and clinical data in section 5.3. Since
METABRIC comes with OS labels only, OS was used as the outcome variable in this
section.
3.1. Cohort Selection
TCGA breast invasive carcinoma (BRCA) was used in section 5.3 as target cohort. In
section 5.4 we perform multi-task learning experiments on every possible pair of target and
auxiliary cohorts chosen from a subset of cancer types. Out of the 33 TCGA cancer types,
we selected those with PFI event rate higher than 20%. We used the performance of Cox-
ElasticNet (Park and Hastie, 2007) on each of these cancer types as a measure of outcome
label quality, and used only those cancer types where Cox-ElasticNet achieved a c-index of
60% and higher, leaving us with adrenocortical carcinoma (ACC), cervical squamous cell
carcinoma (CESC), lower-grade glioma (LGG), kidney renal clear cell carcinoma (KIRC),
kidney renal papillary cell carcinoma (KIRP), mesothelioma (MESO), and pancreatic ade-
nocarcinoma (PAAD). ACC and MESO could not be used as target cohorts since their
small sample sizes did not allow for reliable model evaluation. All of the mentioned cancer
types were used as auxiliary cohorts.
We discarded samples that did not have gene expression data or outcome labels. A
summary of sample sizes and event rates of datasets after this preprocessing step is given in
Table 1. Z-score normalization and 3-NN missing data imputation were performed on gene
expression data. No further feature selection or dimensionality reduction was performed. In
section 5.3, we found the intersection of Hugo IDs present in both BRCA and METABRIC
datasets (17272 genes), and discarded the genes that were absent in either dataset.
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a. Multi-task Model (MTL) b. Adversarial Multi-task Model (ADV-MTL)
Figure 1: Model architectures used.
4. Methods
In cases where the target and auxiliary tasks are similar and their corresponding samples
come from similar distributions, a natural approach is to simply combine (i.e. concatenate)
the target and auxiliary datasets and train a single-task model on the combined training
data, as done is Yousefi et al. (2017). We implement this approach as a baseline using both
Cox-ElasticNet and SurvivalNet to provide two performance baselines.
But the assumption that the two cohorts come from the same distribution rarely holds.
Comparisons of survival time between pairs of samples are integral to the Cox log-likelihood
loss function. When one naively combines datasets to train a model with a single Cox loss,
in addition to comparisons within target cohort and within auxiliary cohort, comparisons
between these cohorts contribute to the loss. Since the difference between distributions of
these cohorts could be due to clinically insignificant factors (such as batch effects), these
between-cohort comparisons could be misleading in training. Our first proposed model
aims to eliminate this potentially misleading signal from the training process via multi-task
learning:
Multi-task learning (MTL): This proposed extension of SurvivalNet model comprises
one Cox loss node per each task. Each Cox loss node is responsible for one cohort only, so
that only within-cohort comparisons contribute to the loss (See Figure 1a). The objective
function of the MTL model is the sum of all Cox losses:
LMTL =
T∑
t=1
LCox(fW (X
t), Y t, β) (5)
where fW is the SurvivalNet model. All parameters of MTL, β and W , are shared among
tasks.
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Although we are encouraging sparse representation learning via the bottleneck architec-
ture of the MTL model, that does not adequately force the model to learn a task invariant
representation. The model may learn a sparse representation, but still have enough param-
eters to be able to discriminate between samples from different cohorts and process them
differently. The adversarial model described below addresses this limitation.
Adversarial model (ADV): This models extends SurvivalNet by addition of an adver-
sarial cohort classification loss. Let Xcomb = {x1, ..., xM} and Ycomb = {y1, ..., yM} denote
the combination of all Xt and Y t, respectively, including M samples in total. A set of
one-hot vectors YD = {d1, ..., dM} indicate cohort membership, so that dit = 1 means that
the ith sample belongs to the tth cohort. A cohort discriminator is trained to assign the
transformed samples zi = fW (xi) to the cohort they belong to. This component of the
model is a multi-class logistic regression with a softmax cross-entropy loss. It comprises
a linear transformation gθ mapping zi to a T-dimensional vector, where T is the number
of tasks, and a softmax function that transforms the result to a T-dimensional vector of
probabilities. The predicted probability that sample i belongs to cohort t is given by:
dˆit =
egθ(zi)t∑T
k=1(e
gθ(zi)k)
,
and the objective function of the discriminator LD is the cross-entropy between predicted
probabilities and cohort lables:
LD(fW (Xcomb), YD, θ) = γ
M∑
i=1
T∑
t=1
−dit log dˆit (6)
This loss function only trains the parameters of the discriminator, namely θ the parameters
of the linear function gθ.
Simultaneously, a risk predictor is adversarially trained to learn a cohort-invariant rep-
resentation that misleads the cohort classifier, in addition to learning to predict risk of
event. The objective function of the risk predictor component of the model is:
LR = LCox(fW (Xcomb), Ycomb, β)− γLD(fW (Xcomb), YD, θ) (7)
LR trains the parameters of the risk predictor β as well as W . By updating W with an
objective function that is the opposite of that of the discriminator, we encourage learning
a representation of data in which samples from different cohorts are indistinguishable. γ
controls the contribution of the adversarial loss to representation learning.
Adversarial multi-task model (ADV-MTL): Combining the MTL and ADV model
described above, we allocate one Cox loss node for each cohort and additionally employ an
adversarial cohort classification (See Figure 1b). The discriminator loss function is the same
as given by Equation 6 while the rest of the model is trained with the following objective:
LR =
T∑
t=1
LCox(fW (X
t), Y t, β)− γLD(fW (Xcomb), YD, θ) (8)
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5. Results
5.1. Model selection and training
We use random stratified sampling to sample 60% of target data as training and use the
remaining 40% as hold-out testing data. Stratified sampling ensures similar event rates in
training and testing sets.
Training set is augmented with any auxiliary data at this stage if the experiment calls
for it. For model selection, grid search cross validation is performed on the training set
using 5 randomly sampled training (80% of target training data + auxiliary data) and
validation sets (20% of target training data). The selected model is then evaluated on the
hold-out testing data. We repeat this procedure on 30 randomly sampled training and
testing sets and use re-sampled t-test and paired re-sampled t-test (Dietterich, 1998) to
provide confidence intervals and significance analysis.
A single hidden layer with 50 hidden units was used in all neural networks. Learning
rate, drop-out regularization rate, and L2 regularization rate of neural network parameters
W , and the weight of the discriminator loss γ were tuned via grid search. In Cox-ElasticNet
experiments, we tuned the regularization rate γ and the mixture coefficient α.
The same sampling, training, model selection and evaluation procedures was used in all
experiments. All software and parameters to reproduce the results presented in this section
are publicly available at [GITHUB LINK].
5.2. Evaluation Metric
We measured model performance using concordance index (CI) that captures the rank
correlation of predicted and actual survival (Harrell Jr et al., 1982), and is given by:
CI(β,X) =
∑
P
I(i,j)
|P | (9)
I(i, j) =
{
1, if rj > ri and tj > ti
0, otherwise
(10)
Where P is the set of orderable pairs. A pair of samples (xi, xj) is orderable if either the
event is observed for both xi and xj , or xj is censored and tj > ti. Intuitively, CI measures
the pairwise agreement of the prognostic scores ri, rj predicted by the model and the actual
time of event for all orderable pairs. Optimizing the cox partial likelihood (Equation 2) has
been shown to be equivalent to optimizing CI (Steck et al., 2008).
5.3. Combining two breast cancer cohorts
This section investigates the integration of two breast cancer cohorts from independent
studies. We use BRCA as target and METABRIC as auxiliary cohort. Both of these
cohorts are diagnosed with breast cancer, and have overall survival labels. In such cases
where similar biological processes determine the outcomes, one would expect naively pooling
cohorts together to lead to better predictions on each of the cohorts. This is the expectation
particularly in this case where the auxiliary cohort has twice the number of samples as the
target cohort and three times the event rate. We train SurvivalNet and Cox-ElasticNet
9
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p=4e-6 p=0.83
p=1e-3
BRCA
Figure 2: One solution to data insufficiency is to obtain similar cohorts and combine them with target
training data. METABRIC gene expression and clinical data were combined with BRCA training
data to improve performance on BRCA using models described in section 4. BRCA only refers
to performance of SurvivalNet when trained on BRCA only. The horizontal line indicates the
performance of Cox-Elasticnet trained on naive combination of cohorts. Shaded areas indicate
95% confidence intervals. Paired t-test p-values are provided for some comparisons.
on the naive combination of BRCA and METABRIC as a two baselines, and compare the
results to MTL, ADV, and ADV-MTL models as shown in Figure 2.
Surprisingly, we observe that simply adding METABRIC to training data has no effect
on prediction c-index on BRCA (p=0.83). This implies that the distributions of the two
datasets are so different that comparisons made between them are not providing useful
insights to the model. Therefore, we eliminate these between-cohort comparisons by training
a MTL model and observe a significant improvement (p=3e-4). Addition of adversarial
classification loss to SurvivalNet lead to a slight improvement over naive SurvivalNet, while
combining the MTL and ADV approaches into ADV-MTL significantly outperforms all
other methods. The significance of the improvement achieved by ADV-MTL from a machine
learning standpoint is discussed in section 5.6.
5.4. Combining cohorts with different cancer types
We repeat the experiments of section 5.3 this time using cohorts diagnosed with different
cancer types. As explained in section 3.1, we use five cancer types as target and seven
cancer types as auxiliary cohorts, performing experiments on each possible pair of target
and auxiliary cohorts. Results of these experiments are summarized in Tables 2 and 3 in
terms of average c-index achieved on target test set.
Table 2 summarizes the result of training SurvivalNet on the naive combination of
target and auxiliary cohorts (NAIVE). The last column provides c-index of SurvivalNet
after training on target cohort only. This naive approach leads to either significant (p<0.01)
deterioration or no significant difference in performance compared to SurvivalNet trained
on target only, achieving significant improvement only in one case. ADV-MTL, on the other
hand, achieves significant improvement over target-only setting in 10 cohort combinations
(See Table 3).
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+ACC +CESC +LGG +KIRP +KIRC +PAAD +MESO
Target-
only
CESC
63.82
(±1.79) -
62.28*
(±1.91)
63.08
(±1.87)
61.49*
(±1.33)
60.50*
(±1.63)
65.43
(±1.44)
64.06
(±1.60)
LGG
71.12
(±0.84)
70.87
(±0.96) -
69.45
(±1.39)
67.99*
(±1.05)
71.27
(±0.86)
70.76
(±0.70)
70.62
(±0.74)
KIRP
75.14
(±1.98)
74.17
(±1.93)
73.48
(±1.84) -
74.38
(±1.90)
74.58
(±1.36)
74.89
(±1.77)
74.62
(±1.83)
KIRC
71.20
(±1.14)
70.31
(±0.81)
70.62
(±1.08)
71.03*
(±1.16) -
70.28
(±1.13)
67.32*
(±1.36)
69.69
(±1.06)
PAAD
63.77
(±1.43)
59.25*
(±1.54)
63.22
(±1.43)
62.24*
(±1.81)
58.80*
(±2.13) -
63.49
(±1.50)
63.78
(±1.40)
Table 2: Performance of SurvivalNet (c-index) when trained on naive combination of target data (rows) and
auxiliary data (columns). Performance after training on target data only has been provided for
reference. Numbers is parentheses are 95% confidence intervals. All improvements are boldened.
* marks significant differences (p–values less than 0.01).
+ACC +CESC +LGG +KIRP +KIRC +PAAD +MESO
Target-
only
CESC
64.32
(±1.75) -
63.41
(±1.57)
61.54
(±1.63)
62.92
(±1.84)
60.64
(±1.58)
65.26
(±1.57)
64.06
(±1.60)
LGG
71.04
(±0.93)
71.80*
(±1.05) -
71.23*
(±0.71)
71.00
(±0.97)
72.24*
(±0.78)
70.42
(±0.74)
70.62
(±0.74)
KIRP
76.49*
(±1.89)
72.24*
(±1.90)
74.91
(±1.68) -
75.60
(±1.78)
75.0
(±1.64)
75.45
(±1.9)
74.62
(±1.83)
KIRC
72.59*
(±0.92)
72.18*
(±0.85)
72.50*
(±0.74)
73.14*
(±0.75) -
71.83*
(±1.0)
73.53*
(±0.94)
69.69
(±1.06)
PAAD
64.48
(±1.66)
62.66*
(±1.58)
64.17
(±1.33)
63.99
(±1.42)
64.20
(±1.49) -
64.14
(±1.66)
63.78
(±1.40)
Table 3: Performance of ADV-MTL model when trained on combination of target data (rows) and aux-
iliary data (columns). Performance of SurvivalNet after training on target data only has been
provided for reference. Numbers is parentheses are 95% confidence intervals. All improvements
are boldened. * marks significant differences (p–values less than 0.01).
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CESC KIRC KIRP LGG PAAD
p=6e-3 p=5e-3 p=0.1 p=9e-9 p=4e-2
Figure 3: Progression-free survival (PFI) prediction performance with and without multi-task learning
with overall survival (OS). Comparison performed on five different cancer types. Significance
levels are shown on the plot for each comparison.
5.5. Combining multiple outcome labels for the same cohort
As discussed in section 3.1, TCGA samples may have multiple outcome labels. Overall
survival (OS) labels are noisier, but simpler to obtain since the patients are either deceased
or alive at the end of the study. As shown in Table 4, for some patients, a new tumor
event is never observed (or recorded) during the study (censored PFI), while their overall
survival outcome is observed (deceased by end of study). In such cases, overall survival
could provide an extra supervision signal in training a predictive model that originally
targets PFI prediction.
We use the MTL model to simultaneously use PFI and OS outcomes in training. Target
and auxiliary domains are the same, so there is no need for adversarial domain-invariant
representation learning. What differentiates the tasks from each other is the the predictive
function P (Y |X). Results are summarized in table 4. Multi-task learning with PFI and OS
always leads to improved PFI prediction performance compared to single-task SurvivalNet
trained with PFI labels only.
5.6. Significance of Results
To provide an insight into the significance of the improvement achieved by our models, we
look at the learning curve of SurvivalNet on two target datasets. Learning curves were
obtained by training SurvivalNet on incrementally more training samples (using the same
procedure described in section 5.1) and testing on a fixed sized test set (40% of data, con-
sistent with the rest of experiments). As shown in Figure 4, the performance improvement
achieved by ADV-MTL over SurvivalNet trained on the full training dataset exceeds the
improvement resulting from doubling the size of target training data (from 50% to 100%
of training set). Considering the cost of obtaining labeled samples, we believe the ADV-
MTL approach can save researchers resources by enabling the integration of heterogeneous
cohorts in training.
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Cancer type
PFI+OS
c-index
Improvement
over PFI
Censored PFI
and observed
OS
CESC 65.83 1.69% 5.26%
KIRC 76.55 2.12% 11.81%
KIRP 76.55 1.35% 5.19%
LGG 72.15 1.75% 1.75%
PAAD 65.12 1.34% 9.55%
Table 4: Progression-free survival (PFI) prediction performance with and without multi-task learning with
overall survival (OS). Comparison performed on five different cancer types. Percent of samples
in each cohort with censored PFI and observed OS is given in the last column.
a. SurvivalNet learning curve on LGG b. SurvivalNet learning curve on BRCA
Figure 4: Learning curves of SurvivalNet on two datasets. Size of training data is gradually increased
from 10% of the original size to 100%. The horizontal line depicts the performance of our ADV-
MTL approach. Error bars and the shaded area correspond to confidence intervals of the mean
c–index.
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6. Discussion and Future Work
Data insufficiency is known to hinder successful application of machine learning models to
high dimensional genomic data. In this paper, we study two neural network models for
learning from combinations of heterogeneous datasets to tackle this issue. Significant im-
provement was achieved by identifying and integrating independent cohorts diagnosed with
the same cancer type, and training the proposed models with the integrated data. We show
how even genomic data obtained from different tumor sites can be used to augment train-
ing data and improve performance. Moreover, different outcome labels of the same cohort
were used in multi-task learning to alleviate the outcome censoring issue and significant
improvement was observed in most cases.
We show that the integration of heterogeneous datasets using our proposed method is a
reasonable alternative to acquisition of new training data from the target distribution which
may be expensive or impossible due to practical constraints (funding, availability, clinical
setting, etc).The ideal solution to any data insufficiency issue is enhanced data collection and
standardization efforts. However, in settings where this is impractical, employing techniques
like ADV-MTL and MTL can help address this at no extra cost. While our work focused
on combining datasets from the same feature space, future work may apply or extend the
proposed models to scenarios 2 and 4 introduced in Section 2.2, namely multi-task learning
using datasets with different feature spaces and/or label spaces. Studying different cancer
subtypes (eg. breast cancer histologic subtypes) under a multi-task learning setting could
also lead to improved prediction.
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